CYP 3.13% 33.0¢ cynata therapeutics limited

The Phase I/IIb Nereid Study Is Now Registered, page-3

  1. 1,928 Posts.
    lightbulb Created with Sketch. 1147
    MCA -maybe mesenchymal cells from autologous sources - so specifically ipscs where the four factors involved in doing the induction of pluripotency are applied to an autologous source and what is then done is that the ipscs are directed towards a mesenchymal fate --- is that what is going on there ?
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
0.010(3.13%)
Mkt cap ! $59.27M
Open High Low Value Volume
31.0¢ 33.0¢ 30.0¢ $36.91K 116.8K

Buyers (Bids)

No. Vol. Price($)
1 3000 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 28248 3
View Market Depth
Last trade - 16.10pm 04/06/2024 (20 minute delay) ?
Last
32.0¢
  Change
0.010 ( 1.59 %)
Open High Low Volume
30.0¢ 32.0¢ 30.0¢ 37199
Last updated 13.23pm 04/06/2024 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.